Acute non-ST-segment elevation myocardial infarction (NSTEMI) is in the spectrum of acute coronary diseases (ACS) and often life-threatening. Several methods were developed to assess the early and late risk. As a noninvasive, convenient, and cost-effective approach, ECG was done repeatedly on ACS patients during hospitalization to monitor disease and evaluate the risk. Several However, the prognostic ability of ECG seems not limited to that. 
sion ≥0.05 mV in two contiguous leads and/or T inversion ≥0.1 mV in leads with prominent R wave or R/S ratio>1) without persisting two contiguous leads with ST elevation; (c) imaging evidence of new loss of viable myocardium or new regional wall motion abnormality (Thygesen et al., 2012) . The subjects enrolled in this study had to meet the following inclusion criteria as well: (a) older than 18 years old; (b) survive the hospitalization and be discharged from hospital upon recovery; (c) the ECGs on admission and discharge were available; (d) equal or greater than 50% stenosis of at least one of the main vessels of coronary arteries was confirmed by coronary angiogram.
Patients with any conditions listed as below were excluded: severe hepatorenal dysfunction, pregnancy, malignant tumors, active bleeding, hematological system diseases, or hypokalemia (blood potassium < 3.5 mM) at admission. Patients with ECG of nonsinus rhythm, branch bundle block were rejected because parts of ECG parameters were unobtainable or deviant. Excluded either were patients with symptoms completely relieved when arrived at our medical center, who were transferred for elective PCI.
All subjects enrolled were treated in accordance with latest guidelines of NSTEMI management at the time, and the therapeutic process was not interfered with by this study. This study was permitted by the local ethical recommendations of the hospital's committee on human research, and the informed consents were signed by subjects themselves or their legally authorized persons before this study initiated.
| Clinical data collection and ECG parameter measurement
Standard 12-leads ECGs (25 mm/s and 1 mv, mostly using GE Medical Systems, Milwaukee, WI, USA) were performed on each subject on admission and discharge, respectively. ECGs at admission were defined as recorded at the first medical contact or in our emergency department before revascularization after symptoms arose. ECGs at discharge were defined as the last ECG recorded before patients left hospital at the same stay. Measurements of ECGs were performed manually by using ECG calipers and hand magnifiers. The duration and amplitude of negative P terminal force were measured following the protocol proposed by Morris et al. (1964) when it was present in leads V1. In addition, numbers of leads showing ST depression ≥0.1 mV were counted up.
To ensure the reproducibility of the measuring, two medical staffs completed all measurements independently. For every measurement, repeated measuring on three sequential waves in the optimal leads was required, and the median values were recorded as measuring results. Approximate reads of within ±0.005 s in duration and ±0.125 mm in amplitude were acceptable. When differences of measuring results between two measurers existed, the average was calculated. The intra-class correlation coefficients (ICC) of intrameasurer variability was 0.758 (0.323-0.929, 95% confidential interval (CI)) for P-wave duration, 0.876 (0.608-0.965, 95% CI) for PtfV1, 0.909 (0.672-0.975, 95% CI) for QRS duration, respectively; the ICC of inter-measurer variability was 0.856 (0.571-0.959, 95% CI), 0.961 (0.867-0.989, 95% CI), 0.755 (0.341-0.927, 95% CI), respectively.
We reviewed each participant's coronary angiogram and divided them into two sorts, single-or multi-vessel lesion. Single-vessel lesion was defined as only one main coronary vessel developing ≥50% stenosis, while multi-vessel lesion meant that two or three main vessels were ≥50% obstructed. Other associated clinical information was collected for each patient, including smoking history, diabetes mellitus, laboratory test results, heart function grade of NYHA, and GRACE risk score at admission.
Variations of each electrocardiographic measurement of same patients during hospitalization were calculated as Delta: Delta of P-wave duration (Delta-P, ms) was duration of P wave at discharge minus that at admission; Delta of QRS complex duration (Delta-Q, ms) was duration of QRS at discharge minus that at admission; Delta of numbers of leads showing ST depression (Delta-N) was numbers of leads showing ST depression at discharge minus that at admission. Positive delta values and zero were designated as Delta (+) while negative were Delta (−). We assigned subjects into two groups, respectively, according to these three categories above, Delta (+) group and (−) group. Patients with Delta-P (−) were assigned to "reduction" group while Delta-P (+) were assigned to "no reduction" group; Patients with Delta-Q (−) were assigned to "not prolonged" group while Delta-Q (+) to "prolonged" group; Patients with Delta-N (−) were assigned to "no depression or decrease" group while Delta-N (+) to "no change or increase" group. As for PtfV1, ≤−0.03 (mm * s) was considered as PtfV1 positive, while >−0.03 (mm * s) was negative. According to different changing trend of PtfV1 values during hospitalization, we assigned subjects into four groups: If the values of PtfV1 during hospitalization were consistent, patients were assigned into persistent (PtfV1) negative or positive group; if the values were inconsistent, then into other two groups: normalization group for patients showing positive PtfV1 at admission but turning to negative at discharge, new-onset positive group for patients with the opposite trend.
| Follow-up and statistics analysis
Follow-up was done by coworkers, who did not take part in prior clinical information collection and analysis, mainly through conducting telephone follow-up to patients themselves or their close family members. Whether and when events occurred and whether patients were taking medication as prescribed were collected. The average of follow-up time was 38.4 (±16.1) months, and the rate of loss to follow up was 7.6%. All follow-up results were consistent with electronic medical records system in our center.
The primary endpoint in this study was a composite endpoint of major adverse cardiovascular events (MACEs), including nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death.
The second endpoint was a composite endpoint of all-cause death, nonfatal stroke, nonfatal myocardial infarction, and readmission due to heart failure.
Continuous variables were presented as mean ± SD or median (interquartile range) and categorical variables as percentage or frequency. Comparisons of baseline data between groups were performed using one-sample t test for continuous variables or Pearson χ 2 test for categorical variables. The Kaplan-Meier estimate was conducted for survival analysis, and differences between groups were assessed using a log-rank test. Factors with p ≤ 0.10 analyzed by univariate analysis were taken into Cox proportional hazards model. Two-sided p value <0.05 was considered statistically significant. All data analyses were performed using windows software IBM SPSS statistics, version 22.
TA B L E 1 Clinical baseline data of all patients and groups divided by P-wave duration

| RE SULTS
A total of 170 patients with 140 males were included in our study.
Clinical characteristics of all subjects and groups divided by P-wave duration were shown in Table 1 . The maximum age in our study was 90 years, the minimum was 39, and the mean of age was 65.7 ± 11.2.
There were totally 10 subjects (5.9%) undergoing percutaneous cor- Data and medical history between groups were not found statistically significant. Vital signs such as systolic pressure and heart rate recorded at admission, laboratory test results of blood fat, urine creatinine, BNP, and TPN-T were analyzed and listed separately, and no statistical significance was found either comparing between groups.
In this study, total 340 ECGs of 170 patients were taken into scrutiny.
| P-wave duration
P-wave duration in this study differed from 50 to 140 ms. The average of P-wave duration was not significant between admission and discharge [99 ± 15 ms vs. 97 ± 14 ms, p = 0.071]. There were 33.5% of admission ECGs and 27.1% of discharge ECGs showing P wave ≥110 ms duration. By comparing the P-wave duration at discharge and admission, differences between at discharge and admis- 
| P-wave terminal force in lead V1
In present study, PtfV1 values ranged from 0 to −0.9000 mm * s, and positive rate was 49.4% for admission, 47.6% for discharge, respectively. By comparing PtfV1 between admission and discharge, subjects were assigned into four groups according to dif- All results above were shown in Table 2 . Survival diagrams were drawn respectively in Figure 1 .
| QRS duration
| Number of leads showing ST-segment depression
All possible cofounders and ECG parameters were taken into a Cox proportional hazards model analysis. The outcome showed that diabetes mellitus, hypertension stage 3, multiple-vessel lesion, newonset PtfV1 positive group, QRS duration-prolonged group were independent risk factors for the primary endpoints in NSTEMI patients.
The Hazards ratio and p-value were presented separately in Table 3 .
| D ISCUSS I ON
This study reviewed 170 NSTEMI patients' ECGs recorded at admission and discharge and assessed the prognostic value of dynamic changes in ECG parameters including P-wave duration, PtfV1, QRS duration, and numbers of leads showing ST-segment depression.
According to the results, patients with no reduction of P-wave duration, new-onset PtfV1 positive, no change or increase in number of leads with ST-segment depression seem to have a higher risk to
MACEs and a relatively worse prognosis.
As we know it, P wave is generated by the depolarization of atrium and a sign of atrial excitement, while QRS complex is a reflection of F I G U R E 1 Survival curves based on four ECG parameters. Abbreviation as in Table 2 depolarization of ventricle. Prolongation of conduction (p > 110 ms; QRS>100 ms) could be associated with chamber dilatation or muscular hypertrophy, intra-atrial/ventricular conduction delay, elevated chamber pressure, impaired ventricular distensibility (Hancock et al., 2009 ). Especially when P-wave duration is ≥110 ms, which indicates IAB and is a risk factor for congestive heart failure (Goyal & Spodick, 2001 ). Conformed by timely coronary angiogram, NSTEMI patients enrolled in present study lacked in blood flow in at least one of coronary arteries in different levels, causing acute myocardial ischemia and possibly leading to heart failure. The abnormalities of ventricular wall motion because of myocardial ischemia would result in elevation of left ventricular filling pressure and hemodynamic disorders, leading to anatomic atrial/ventricular dilatation or chamber pressure overload and excitement conduction changed with it. Comparing P-wave duration at admission and discharge, the recovering of P-wave duration correlates with improvement of heart function and indicates a better prognosis (Proietti et al., 2012) . In present study, the outcomes differed in patients with different changing trend of P-wave duration and the reduction of P-wave reduction group had a lower rate for MACEs and better survival in comparison with no reduction of P-wave duration group.
However, the same effect of QRS prolongation was not observed, and the mechanism was unclear. The ischemic damage directly to the heart conduction system might interfere with QRS morphology and duration and result would be uncertain. Therefore, careful observation of changes of P-wave duration was clinically useful and could provide information to predict the chance of MACEs in NSTEMI patients.
As addressed in prior studies, dynamic changes in P-wave terminal force in lead V1 (PtfV1) were found to correlate with acute changes in the state of cardiac function and were specific for left atrial enlargement (Birkbeck, Wilson, Hall, & Meyers, 2006; Heikkila, Hugenholtz, & Tabakin, 1973) . The present study showed that patients developing new-onset PtfV1 exceeding 0.03 mm * s in negative value during hospitalization had a higher rate for MACEs after discharge and worse survival time during follow-up. However, patients with persisting positive PtfV1 showed no difference in event incidence or survival time, which was partially inconformity with a preceding study (Li et al., 2015) . A portion of patients with PtfV1 positive at admission might be caused by chronic left atrial enlargement or old myocardial scars and was not due to impairment of acute myocardial infarction. Moreover, the study population was not completely consistent between two studies.
ST-segment depression is proved to associate with myocardial ischemia and patients presented with ST-segment depression in any leads indicate a worse prognosis than those with normal ST segment. However, the quantitative analysis of leads with ST-segment depression seems no additional help to predict outcomes in follow-up (Holmvang et al., 2003; Kaul et al., 2001; Yan et al., 2006) . In results of current study, differences of survival were found between patients grouped by changes in number of leads with ST depression from admission to discharge. After revascularization and standard medicine therapies, comparing it between discharge and admission, no change or even increase in number of leads showing ST-segment depression might suggest a higher risk of adverse events and worse survival outcomes during follow-up.
| LI M ITATI O N S
This study was a retrospective observational study and conducted with a relatively small sample size, which would cause biases and reach an underpowered conclusion. In this study, although we tried to minimize the measuring error, it might still interfere the power of argument and the final conclusions. Besides, the population of this study was a specific portion of MI patients, so the extension of conclusions was limited relatively.
| CON CLUS ION
A 12-leads ECG is commonly seen as an essential and inexpensive modality for diagnosis and risk stratification for ACS patients. This study made an attempt to uncover relationship of ECG parameters changes and long-term prognosis. According to this study, it suggests that discharge ECG with new-onset PtfV1 positive and prolonged QRS duration comparing to admission were independent predictors for MACEs in NTEMI patients. The differences of ECG parameters between at admission and discharge, including P-wave duration, number of leads with ST-segment depression, carried long-term prognostic information for NSTEMI patients.
O RCI D
Guoyong Li
http://orcid.org/0000-0001-6260-2312
R E FE R E N C E S
Baslaib, F., Alkaabi, S., Yan, A. T., Yan, R. T., Dorian, P., Nanthakumar, K., … Goodman, S. 
